Pibrentasvir

Definition: Pibrentasvir is an NS5A inhibitor antiviral agent. In the United States and Europe, it is approved for use with glecaprevir as the combination drug glecaprevir/pibrentasvir (trade name Mavyret in the US and Maviret in the EU) for the treatment of hepatitis C. It is sold by Abbvie. source: Wikipedia

ID

736836002

ID date

7 Jan 2022

Previous ID

34625911000001100

Name

Pibrentasvir